Evolution Wealth Advisors, LLC Biogen Inc. Transaction History

Evolution Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$223.92 - $287.77 $26,870 - $34,532	-120 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $16,696 - $21,773	59 Added 96.72%	120 $34,000
Q2 2021 Jul 22, 2021	BUY	$259.0 - $414.71 $9,065 - $14,514	35 Added 134.62%	61 $21,000
Q2 2020 Jul 27, 2020	BUY	$258.66 - $342.55 $6,725 - $8,906	26 New	26 $7,000
Q1 2020 Apr 22, 2020	SELL	$268.85 - $341.04 $7,527 - $9,549	-28 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$220.06 - $304.07 $440 - $608	2 Added 7.69%	28 $8,000
Q2 2019 Jul 12, 2019	BUY	$219.29 - $241.72 $5,701 - $6,284	26 New	26 $6,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.